Is Spectrum Pharmaceuticals Inc. (SPPI) a opportunity to investors? 2023/02/06 16:32:00 US Post News
The share price of Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) rose to $0.81 per share on Friday from $0.81. While Spectrum Pharmaceuticals Inc. has overperformed by 0.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SPPI rose by 3.15%, with highs and lows ranging from $1.57 to $0.31, […]
Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Has Succeeded In Generating Interest In 2023, The Stock Is Up 119.81% Year-To-Date 2023/02/04 16:30:00 Marketing Sentinel
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI)’s traded shares stood at 1.95 million during the last session, with the company’s beta value hitting 2.13. At the close of trading, the stock’s price was $0.81, to imply an increase of 0.52% or $0.0 in intraday trading. The SPPI share’s 52-week high remains $1.57, putting it -93.83% down since that … Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Has Succeeded In Generating Interest In 2023, The Stock Is Up 119.81% Year-To-Date Read More »
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate 2023/02/03 16:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Spectrum common stock between December 6, 2021 through September 22, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by vi
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm 2023/02/03 13:30:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm 2023/02/02 13:30:00 Business Wire
The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Bluebird bio Seeks Back-to-Back Nods, ''Go'' or ''No-Go'' For Revance''s Botox Rival, Amylyx'' Twin Hurdles And More: September''s Key PDUFA Catalysts Biotech Investors Must Know 2022/08/31 18:52:35 Benzinga
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. New molecular entity approvals drew a blank in August. NMEs are those active moieties that have not been previously approved by the FDA. This should be a cause of concern, as NME approvals are considered a measure of innovation in drug research. The fortunate ones that could take their drugs past the finish line included bluebird bio, Inc. (NASDAQ: BLUE ), Johnson & Johnson (NYSE: JNJ ), and Axsome Therapeutics, Inc. (NASDAQ: AXSM ). ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD ) faced rejection for expanding the label of its Nuplazid to be able to treat Alzheimer’s disease psychosis. CorMedix, Inc.’s (NASDAQ: CRMD ) defencath application was shot down by the FDA for a second time. The review period for Amicus Therapeutics, Inc.’s (NASDAQ: FOLD ) Pompe disease treatment was extended. The Prescription Drug User Fee Act, or PDUFA, date is the period by which the FDA is required to rule on an application submitted by a sponsor company.
SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI 2022/08/27 02:50:00 Kwhen Finance
Spectrum Pharmaceuticals: Revisiting This ''Soap Opera'' (NASDAQ:SPPI) 2022/08/21 09:46:56 Seeking Alpha
SPPI focuses on developing and commercializing novel and targeted drug products with a primary focus in oncology. Read more to see the full investment analysis.
Spectrum Pharmaceuticals (SPPI) Q2 2022 Earnings Call Transcript 2022/08/12 07:30:47 The Motley Fool
SPPI earnings call for the period ending June 30, 2022.
Spectrum Pharma rises 9% after FDA completes re-inspection of manufacturing facility for eflapegrastim drug 2022/08/11 16:52:10 Seeking Alpha
Spectrum Pharma (SPPI) is trading ~9% higher after the company said the U.S. Food and Drug Administration completes re-inspection of drug substance manufacturing facility for…
Enamoring stocks: MEI Pharma, Inc. (NASDAQ:MEIP -0.28%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI -5.82%) 2022/04/15 19:01:53 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enamoring stocks: MEI Pharma, Inc. (NASDAQ:MEIP -0.28%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI -5.82%) appeared first on Stocks Equity .
Spectrum announces resubmitted Eflapegrastim BLA accepted for filing 2022/04/11 13:20:02 Seeking Alpha
Spectrum Pharmaceuticals (SPPI) has announced that the resubmitted Biologics License Application for Eflapegrastim has been accepted for filing.The U.S
HUYA, SPPI and DOYU among pre market gainers 2022/04/11 12:47:33 Seeking Alpha
Veru VERU +31% after interim results for COVID-19 therapy.SailPoint Technologies SAIL +30% acquisition could lead to other cyber security deals, Wedbush says.Iveda Solutions (IVDA) +28%
Looking For A Top Momentum Stock? Why Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Is A Great Pick 2022/04/01 14:30:00 Stocks Register
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares, rose in value on Thursday, 03/31/22, with the stock price up by 2.38% to the previous day’s close as strong demand from buyers drove the stock to $1.29. Actively observing the price movement in the last trading, the stock closed the session at $1.26, falling within a range of $1.25 … Looking For A Top Momentum Stock? Why Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Is A Great Pick Read More »